Literature DB >> 2915233

Analgesic-induced chronic headache: long-term results of withdrawal therapy.

H C Diener1, J Dichgans, E Scholz, S Geiselhart, W D Gerber, A Bille.   

Abstract

Headache characteristics are described in 139 patients with chronic daily or almost daily headaches due to regular intake of analgesics and the short- and long-term results of drug withdrawal. Drug-induced headache was described as dull, diffuse, and band-like, and usually started in the early morning. The mean duration of the original headache (migraine or tension headache) was 25 years; regular intake of drugs and chronic daily headache had started 10 and 6 years prior to withdrawal therapy, respectively. Patients took an average of 34.6 tablets or analgesic suppositories or antimigraine drugs per week containing 5.8 different substances. The drugs most often used were caffeine (95%), ergotalkaloids (89%), barbiturates (64%), and spasmolytics, paracetamol, and pyrazolone derivates (45%-46%). A total of 103 patients (68 migraine, 35 tension or combination headache) were available for interviews at a mean time interval of 2.9 years after an inpatient drug withdrawal programme. Chronic headache had disappeared or was reduced by more than 50% in two-thirds of the patients. Positive predictors for successful treatment were migraine as primary headache, chronic headache lasting less than 10 years, and regular intake of ergotamine. Drug intake was significantly reduced and patients used single substances more often. Patients who originally suffered from migraine, superimposed on the daily headache, also experienced a significant improvement in the frequency of the migraines and their intensity. Migraine prophylaxis through beta-blocking agents and calcium channel antagonists was more efficient after drug-withdrawal therapy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2915233     DOI: 10.1007/BF00314210

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  18 in total

1.  Ergotamine headache.

Authors:  P G Andersson
Journal:  Headache       Date:  1975-07       Impact factor: 5.887

2.  TREATMENT OF CHRONIC TENSION HEADACHE.

Authors:  J W LANCE; D A CURRAN
Journal:  Lancet       Date:  1964-06-06       Impact factor: 79.321

3.  Ergotamine tartrate dependency: features and possible mechanisms.

Authors:  J R Saper; J M Jones
Journal:  Clin Neuropharmacol       Date:  1986       Impact factor: 1.592

4.  Ergotamine and methysergide abuse in patients with migraine.

Authors:  R N Lucas; W Falkowski
Journal:  Br J Psychiatry       Date:  1973-02       Impact factor: 9.319

5.  Letter: Ergotamine-induced headaches.

Authors:  G Wainscott; G Volans; M Wilkinson
Journal:  Br Med J       Date:  1974-06-29

6.  Maprotiline in chronic tension headache: a double-blind cross-over study.

Authors:  R Fogelholm; K Murros
Journal:  Headache       Date:  1985-07       Impact factor: 5.887

7.  Drug dependency in patients with chronic headaches.

Authors:  J L Medina; S Diamond
Journal:  Headache       Date:  1977-03       Impact factor: 5.887

8.  Toxic effects of ergotamine used for migraine.

Authors:  E Hokkanen; O Waltimo; T Kallanranta
Journal:  Headache       Date:  1978-05       Impact factor: 5.887

9.  Ergotamine abuse. Do patients benefit from withdrawal?

Authors:  P Tfelt-Hansen; A Krabbe
Journal:  Cephalalgia       Date:  1981-03       Impact factor: 6.292

10.  Ergotamine abuse: results of ergotamine discontinuation, with special reference to the plasma concentrations.

Authors:  V Ala-Hurula; V Myllylä; E Hokkanen
Journal:  Cephalalgia       Date:  1982-12       Impact factor: 6.292

View more
  29 in total

Review 1.  Medication overuse headache: a focus on analgesics, ergot alkaloids and triptans.

Authors:  Z Katsarava; H C Diener; V Limmroth
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 2.  Headache.

Authors:  T J Steiner; Manuela Fontebasso
Journal:  BMJ       Date:  2002-10-19

Review 3.  [Gordian knot: medication overuse headache].

Authors:  Z Katsarava; G Fritsche
Journal:  Schmerz       Date:  2004-10       Impact factor: 1.107

Review 4.  Medication overuse headache in patients with primary headache disorders: epidemiology, management and pathogenesis.

Authors:  Andrew J Dowson; David W Dodick; Volker Limmroth
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 5.  Cognitive-behavioral issues in the treatment and management of chronic daily headache.

Authors:  Gay L Lipchik; Justin M Nash
Journal:  Curr Pain Headache Rep       Date:  2002-12

6.  Headache disorders: differentiating and managing the common subtypes.

Authors:  Fayyaz Ahmed
Journal:  Br J Pain       Date:  2012-08

Review 7.  Medication-overuse headache: epidemiology, diagnosis and treatment.

Authors:  Espen Saxhaug Kristoffersen; Christofer Lundqvist
Journal:  Ther Adv Drug Saf       Date:  2014-04

8.  A 4-year follow-up of patients with medication-overuse headache previously included in a randomized multicentre study.

Authors:  Knut Hagen; Claus Albretsen; Steinar T Vilming; Rolf Salvesen; Marit Grønning; Grethe Helde; Gøril Gravdahl; John-Anker Zwart; Lars Jacob Stovner
Journal:  J Headache Pain       Date:  2011-01-05       Impact factor: 7.277

Review 9.  Chronic daily headache and the revised international headache society classification.

Authors:  Morris Levin
Journal:  Curr Pain Headache Rep       Date:  2004-02

Review 10.  Headache.

Authors:  N H Raskin
Journal:  West J Med       Date:  1994-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.